John G. Curd,Stewart Kroll,Mark Matteucci,Charles P. Hart,Jian-Xin Duan,Jessica D. Sun
申请号：
US14574082
公开号：
US20150258125A1
申请日:
2014.12.17
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Cancer can be treated by administration of a hypoxia-activated prodrug, such as TH-302, alone or in combination with other anticancer agents and/or radiation therapy. In combination therapy, the hypoxia-activated prodrug and another anticancer agent or radiation therapy may be administered within the same 24-hour period, and administration of the hypoxia-activated prodrug may be completed prior to beginning administration of the other anticancer agent or radiation therapy.
